New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List ...Middle East

ROCKVILLE, Md. and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the new...

Read More Details
Finally We wish PressBee provided you with enough information of ( New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List )

Also on site :

• Final Palisades fire evacuation order lifted
• A hillside of white crosses fuels a misleading story about South Africa’s farm killings
• Crash in Rosemont area leaves woman dead, 2 others injured